MOUNTAIN VIEW, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced ...

"We are pleased with our operational and clinical execution this quarter and look forward to sharing additional clinical data ...

Operator instructions] I would now like to turn the conference over to Aron Feingold, vice president of investor relations ...

The public charter academy, once the subject of controversy over charging parents tuition and fees, will expand into ninth ...

Greetings and welcome to Rigel Pharmaceutical's Financial Conference Call for the Third Quarter 2024. At this time, all participants are in a listen-only mode. A brief question and answer session will ...

Q3 2024 Earnings Conference Call November 7, 2024 11:00 AM ETCompany ParticipantsKim Golodetz - Alliance Advisors ...

The Hechinger Report covers a SUNY New Paltz initiative to turn classes into living labs that combine instruction with efforts to improve sustainability on campus.

A recent Open Enrollment study by Corebridge Financial reveals gaps in the open enrollment process. Interviewing Terri ...

It's the time of year that Medicare and Medicare Advantage plans are open for new signups and changes. You'll need to act now ...

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative ...

A record number of Californians will now have access to the highest level of financial assistance ever provided through state ...

Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG) to enable interim ...